Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Phylogenetic Trees03:21

Phylogenetic Trees

Phylogenetic trees come in many forms. It matters in which sequence the organisms are arranged from the bottom to the top of the tree, but the branches can rotate at their nodes without altering the information. The lines connecting individual nodes can be straight, angled, or even curved.
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
Methods of Medium Optimization01:28

Methods of Medium Optimization

Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cancer Immunotherapies Ignited by a Thorough Machine Learning-Based Selection of Neoantigens.

Advanced biology·2024
Same author

Machine learning-assisted search for novel coagulants: When machine learning can be efficient even if data availability is low.

Journal of computational chemistry·2024
Same author

Toward a quasiphase transition in the single-file chain of water molecules: Simple lattice model.

The Journal of chemical physics·2023
Same author

Complex machine learning model needs complex testing: Examining predictability of molecular binding affinity by a graph neural network.

Journal of computational chemistry·2022
Same author

On the Verge of Life: Distribution of Nucleotide Sequences in Viral RNAs.

Biosemiotics·2021
Same author

Toward efficient generation, correction, and properties control of unique drug-like structures.

Journal of computational chemistry·2021

Related Experiment Video

Updated: May 28, 2026

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

When Trees Guide Molecules: Multiobjective Search in de Novo Drug Design.

Maksym Druchok1,2, Andrij Rovenchak1,3

  • 1SoftServe, Inc., 2d Sadova Street, 79021 Lviv, Ukraine.

Journal of Chemical Information and Modeling
|May 27, 2026
PubMed
Summary
This summary is machine-generated.

This study introduces a computational framework for de novo drug design, optimizing molecules against orexin and histamine receptors. The approach efficiently navigates chemical space for selective or multitarget inhibitors with desirable properties.

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Related Experiment Videos

Last Updated: May 28, 2026

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Area of Science:

  • Computational chemistry and cheminformatics
  • Drug discovery and development
  • Machine learning in medicinal chemistry

Background:

  • Molecular design faces challenges in exploring vast chemical spaces for bioactive compounds.
  • Discovering molecules with selective or polypharmacological inhibitory profiles is a key hurdle in drug development.

Purpose of the Study:

  • To present a computational framework for de novo generation of drug candidates.
  • To optimize molecules targeting orexin and histamine receptors with desired selectivity or multitarget activity.
  • To integrate guided exploration strategies for efficient chemical space navigation.

Main Methods:

  • Integration of Monte Carlo tree search with predictive machine learning models.
  • Utilization of expert-defined rules for de novo molecule generation.
  • Multiobjective optimization including inhibitory action, toxicity, aqueous solubility, and melting temperature.

Main Results:

  • Demonstration of a hybrid approach for efficient exploration of chemical space.
  • Generation of inhibitor candidates with optimized pharmacological profiles and properties.
  • Scalable pathway for in silico drug design toward selective or multitarget agents.

Conclusions:

  • The developed framework enables efficient navigation of chemical space for drug discovery.
  • The hybrid approach facilitates the design of molecules with desired selectivity or polypharmacological profiles.
  • This method offers a scalable solution for in silico optimization in drug design.